Back to Agenda
PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology
Session Chair(s)
PPD, part of Thermo Fisher Scientific
United States
The proliferation of real-world data (RWD) sources and advancements in technology (e.g.,artificial intelligence (AI), wearables) have fueled the use of real-world evidence (RWE)in drug development. Globally diverse, trusted data sources and impactful AI and digital technologies provide faster, more comprehensive curated data for optimized study design and analysis. This intersection provides invaluable insights to help decision makers make smarter, faster decisions to advance and optimize product development.
Speaker(s)
Speaker
Peter Wahl, MS
CorEvitas, part of PPD clinical research business of Thermo Fisher Scientific, United States
Vice President, Global Head of Scientific Affairs
Speaker
Ariel Berger, MPH
Evidera, part of PPD clinical research business of Thermo Fisher Scientific, United States
Executive Director, Integrated Solutions, Real-World Evidence
Speaker
Gino Pirri
PPD, part of Thermo Fisher Scientific, United States
VP Head Product & Technology
Speaker
John Van Hoy, MBA
PPD, part of Thermo Fisher Scientific, United States
Executive Director, Data Science & Advanced Analytics
Have an account?